Individuals Discontinuing Anti-Obesity Injections Gain Back Weight at a Quadrupled Rate Compared to People Using Diet and Exercise

Fresh analysis indicates that patients who stop using popular weight-loss injections like Wegovy and Mounjaro may regain lost weight much more quickly than those who halt traditional lifestyle plans.

Findings released in a prominent medical journal demonstrates that while overweight people often shed a large proportion of their total mass while undergoing treatment, the weight comes back at an estimated rate of nearly a kilo each month once they quit.

"Individuals buying these treatments need to be cognizant of the danger of rapid weight regain when the medication concludes," warns expert Dr. Susan Jebb.

That rate of recovery suggests a reversion to pre-treatment weight within about a year and a half.

Weighing Therapies

The study, which reviewed 37 of studies involving over 9,000 of participants, compared the effects of these new drugs with older methods.

Researchers emphasize that individuals who shed pounds through dieting generally experience a more gradual creep back—perhaps 100 grams monthly—once they finish.

Explaining the Quick Regain

Nutrition scientists believe the mode of action of the jabs explains the accelerated weight return.

These medications imitate a body's own chemical called GLP-1, which helps regulate hunger.

"Artificially providing the hormone levels far above than the body's typical production may cause the body to generate a reduced amount of its endogenous hormone, and may also reduce sensitivity to its effects," noted Dr. Adam Collins, a nutrition researcher.

"Discontinuation of this medication results in hunger is no longer kept in check, making excessive eating a significant risk."

A Chronic Issue?

Health authorities advise the injections for people with obesity-related health risks, alongside recommended diet and exercise modifications.

Many experts say that, given the high risk of relapse, the treatment should be considered long-term.

This opinion is echoed by pharmaceutical companies, who say that the findings "underscore the persistent character of excess weight," comparing it to managing conditions like hypertension.

User Accounts

Individuals who have discontinued the jabs describe a intense resurgence of hunger.

"It felt as if something activating and you become extremely hungry," recalled an individual.

This challenge is compounded if patients have not developed permanent lifestyle or habit modifications during therapy.

Significant Use

Figures suggest that a significant number of people in the UK have tried weight-loss jabs in the past year, with demand being substantial.

• Adoption is greater among women compared to men.
• The 40s and 50s age group shows the highest usage rates.
• Many access the drugs through private healthcare rather than the NHS.

Finally, experts caution that while these medications are powerful tools for shedding pounds, they are not a magic solution and maintained weight loss hinges on combined behavioural support.